Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. The BIOWAVE (ba booom) Message Board

My 2013 Call............given the facts I understa

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 226
Posted On: 02/17/2013 12:39:49 PM
Avatar
Posted By: biomanbaba

My 2013 Call............given the facts I understand TODAY



I have taken to calling the MAG7 and the CB7 the BIG 14. Within

the group I always have focus stocks. For the asset allocators in

my group those are what to OVERWEIGHT right now. For the buy and

hold group the focus stock represent the stocks you MUST OWN NOW

if you are building from a small capital base and CANNOT

own all 14 in a balanced portfolio AT THIS TIME. The large account

buy and hold crowd should have an equal amount of all 14 and for

them my updates are nothing but continuing DD and a source of amusement.


For the remainder of 2013 my PRIME FOCUS stocks are SBFM and CTIX

For SBFM the completion of their pre trial studies and Filing of

their IND is fast approaching. After that we look to their TRIAL LAUNCH.

These events ARE LIKELY to produce for us A RUN just like the

CTIX Run from 50 cents to $2.40 last fall. SBFM addresses 80% of Breast

Cancer and their IND news and TRIAL LAUNCH news will produce just

as much MEDIA NOISE as the KEVETRIN trial launch.


CTIX remains atop the focus list because their Phase I trial results

will be DUE in the 4 QTR. A great report could turn their chart into

another PCYC. Because of the terrible condition of the trial patients

going in; ANY Kind of good report should move CTIX to at least $5


Beyond these TWO anyone with capital for three and up should consider

accumulating ISCO on selloffs and bad market days. At some point the

market is going to realize that product sales for them MAY FUND THE COMPANY

to an extent that any dilution for their future CLINICAL programs is

mitigated. Their clinical programs will be coming into view shortly

as IND work progresses. I dont have an IND timeline...but you should

pay attention to KARIN and KELT on that. They both have a razor focus

on this one and are the folks who BROUGHT IT TO MY ATTENTION.



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us